A Phase 1 Randomized, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Enteric-Coated Stabilized Sulforaphane (SFX-01) in Male Participants.

Saved in:
Bibliographic Details
Title: A Phase 1 Randomized, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Enteric-Coated Stabilized Sulforaphane (SFX-01) in Male Participants.
Authors: Clack G; TheraCryf PLC (Formerly Evgen Pharma PLC), Block 24, Alderley Park, Congleton Road, Nether Alderley, Cheshire, SK10 4TG, UK. G.Clack@theracryf.com., Moore C; Boyds, Crewe, UK., Ruston L; Seda Pharmaceutical Development Services, Stockport, UK., Wilson D; DJWstats Consulting, Whaley Bridge, UK., Koch A; Simbec-Orion, Merthyr Tydfil, UK., Webb D; Simbec-Orion, Merthyr Tydfil, UK., Mallard N; TheraCryf PLC (Formerly Evgen Pharma PLC), Block 24, Alderley Park, Congleton Road, Nether Alderley, Cheshire, SK10 4TG, UK.
Source: Advances in therapy [Adv Ther] 2025 Jan; Vol. 42 (1), pp. 216-232. Date of Electronic Publication: 2024 Nov 09.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1865-8652
DOI:10.1007/s12325-024-03018-1